LE PROSTACICLINE DI SINTESI NEL TRATTAMENTO DELLA SCLEROSI SISTEMICA PROGRESSIVA: DATI PRELIMINARI

G. L. Biava; A. Camera; I. D'Emilia; P. Galiano; G. Guarnaccia; M. Modica; G. Ruggero; R. Del Porto

LE PROSTACICLINE DI SINTESI NEL TRATTAMENTO DELLA SCLEROSI SISTEMICA PROGRESSIVA: DATI PRELIMINARI

Translated title of the contribution: The use of synthetic prostacyclin in progressive systemic sclerosis

G. L. Biava, A. Camera, I. D'Emilia, P. Galiano, G. Guarnaccia, M. Modica, G. Ruggero, R. Del Porto

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article › peer-review

Abstract

The aim of this study has been to evaluate the use of synthetic Prostacyclin in Progressive Systemic Sclerosis. 14 patients suffering from PSS were treated with an analogue of PGI2 for 3 weeks. Subjective and objective parameters have been analyzed. Most of the patients presented a reduction of vasospastic symptomatology and of other aspects of the disease. We believe that these data have to be confirmed by other studies.

Translated title of the contribution	The use of synthetic prostacyclin in progressive systemic sclerosis
Original language	Italian
Pages (from-to)	941-947
Number of pages	7
Journal	Chronica Dermatologica
Volume	4
Issue number	6
Publication status	Published - 1994

ASJC Scopus subject areas

Dermatology

Cite this

@article{a6e3b7f1ada34234a3e171fbb46db007,

title = "LE PROSTACICLINE DI SINTESI NEL TRATTAMENTO DELLA SCLEROSI SISTEMICA PROGRESSIVA: DATI PRELIMINARI",

abstract = "The aim of this study has been to evaluate the use of synthetic Prostacyclin in Progressive Systemic Sclerosis. 14 patients suffering from PSS were treated with an analogue of PGI2 for 3 weeks. Subjective and objective parameters have been analyzed. Most of the patients presented a reduction of vasospastic symptomatology and of other aspects of the disease. We believe that these data have to be confirmed by other studies.",

keywords = "Progressive Systemic Sclerosis' treatment-Iloprost effects",

author = "Biava, {G. L.} and A. Camera and I. D'Emilia and P. Galiano and G. Guarnaccia and M. Modica and G. Ruggero and {Del Porto}, R.",

year = "1994",

language = "Italian",

volume = "4",

pages = "941--947",

journal = "Chronica Dermatologica",

issn = "0011-1759",

publisher = "Istituto Dermopatico dell'Immacolata",

number = "6",

}

TY - JOUR

T1 - LE PROSTACICLINE DI SINTESI NEL TRATTAMENTO DELLA SCLEROSI SISTEMICA PROGRESSIVA

T2 - DATI PRELIMINARI

AU - Biava, G. L.

AU - Camera, A.

AU - D'Emilia, I.

AU - Galiano, P.

AU - Guarnaccia, G.

AU - Modica, M.

AU - Ruggero, G.

AU - Del Porto, R.

PY - 1994

Y1 - 1994

N2 - The aim of this study has been to evaluate the use of synthetic Prostacyclin in Progressive Systemic Sclerosis. 14 patients suffering from PSS were treated with an analogue of PGI2 for 3 weeks. Subjective and objective parameters have been analyzed. Most of the patients presented a reduction of vasospastic symptomatology and of other aspects of the disease. We believe that these data have to be confirmed by other studies.

AB - The aim of this study has been to evaluate the use of synthetic Prostacyclin in Progressive Systemic Sclerosis. 14 patients suffering from PSS were treated with an analogue of PGI2 for 3 weeks. Subjective and objective parameters have been analyzed. Most of the patients presented a reduction of vasospastic symptomatology and of other aspects of the disease. We believe that these data have to be confirmed by other studies.

KW - Progressive Systemic Sclerosis' treatment-Iloprost effects

UR - http://www.scopus.com/inward/record.url?scp=0028657180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028657180&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0028657180

VL - 4

SP - 941

EP - 947

JO - Chronica Dermatologica

JF - Chronica Dermatologica

SN - 0011-1759

IS - 6

ER -

LE PROSTACICLINE DI SINTESI NEL TRATTAMENTO DELLA SCLEROSI SISTEMICA PROGRESSIVA: DATI PRELIMINARI

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this